Prediction of Spinal Anesthesia-Induced Hypotension in Cesarian Section: Carotid Artery-Corrected Flow Time Versus Cardiometry
NCT ID: NCT06236217
Last Updated: 2024-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2021-08-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Ability of the Change in Positional Perfusion Index in Predicting Post-spinal Anesthesia Hypotension in Caesarian Section
NCT05269407
Corrected Carotid Flow Time for Predicting Spinal Anesthesia-induced Hypotension
NCT06905535
Norepinephrine to Prevent Hypotension in Ceasrean Delivery
NCT05248932
The Role of Carotid Flow Time-Based Fluid Administration in Caesarean Section
NCT06048497
Predictability of Preoperative Carotid Artery Corrected Flow Time for Hypotension After Spinal Anesthesia in Patients Undergoing Cesarean Section
NCT03631329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Accurate prediction of post-spinal hypotension could enhance clinical decision-making, optimize management, and facilitate early intervention. More than thirty predictors were used in the prediction of post-spinal hypotension including demographic data, hemodynamic variables, postural stress testing, peripheral perfusion indices, volume and fluid responsiveness indices, and genetic polymorphism.
The baseline parameters obtained via the bioreactance-based system may serve as a predictor of post-spinal anesthesia hypotension in parturient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Patients received standard of care with no intervention before spinal anesthesia.
No interventions assigned to this group
Carotid Ultrasound group
The carotid artery corrected flow time (FTc) was used in patients to optimize the volume status before performing spinal anesthesia.
Carotid Ultrasound
The carotid artery corrected flow time (FTc) was used in patients to optimize the volume status before performing spinal anesthesia.
Electrical cardiometry group
Stroke volume variation (SVV) measured by electrical cardiometry (EC) was used to optimize the volume status before performing spinal anesthesia.
Electrical cardiometry
Stroke volume variation (SVV) measured by electrical cardiometry (EC) was used to optimize the volume status before performing spinal anesthesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carotid Ultrasound
The carotid artery corrected flow time (FTc) was used in patients to optimize the volume status before performing spinal anesthesia.
Electrical cardiometry
Stroke volume variation (SVV) measured by electrical cardiometry (EC) was used to optimize the volume status before performing spinal anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) physical status II.
* Gestational age (GA) ≥ 36 weeks.
* Women planned elective cesarean section under spinal anesthesia.
Exclusion Criteria
* Gestational age of \< 36 or ≥40 weeks of pregnancy.
* Pregnancy-induced hypertension.
* Diabetes.
* Cardiovascular diseases, arrhythmia.
* Antepartum hemorrhage.
* Body Mass Index (BMI) above 36 kg/m2.
* Clinical fetal complications.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa Mahmoud Shehab
Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University
Tanta, El-Gharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
34801/07/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.